Trinity Biotech PLC (TRIB) stock
TRIBNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
$5.49−0.34 (-5.84%)
Close on Nov 19, 2026Market cap $102.63MP/E –Yield –
Trinity Biotech shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Trinity Biotech's shares outstanding was 26M at Jun 30, 2018. For fiscal 2025 it was 372M, up 3.4% from the year before. Over ten years it grew 13.0% a year on average. The highest annual figure on record is 372M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 372M | +3.4% |
| FY2024 | Dec 31, 2024 | 359M | +134.6% |
| FY2023 | Dec 31, 2023 | 153M | +92.5% |
| FY2022 | Dec 31, 2022 | 80M | +115.0% |
| FY2021 | Dec 31, 2021 | 37M | -2.0% |
| FY2020 | Dec 31, 2020 | 38M | -62.9% |
| FY2019 | Dec 31, 2019 | 102M | -1.6% |
| FY2018 | Dec 31, 2018 | 104M | -3.7% |
| FY2017 | Dec 31, 2017 | 108M | -5.0% |
| FY2016 | Dec 31, 2016 | 113M | +3.3% |
| FY2015 | Dec 31, 2015 | 110M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2018 | Jun 30, 2018 | 26M | – |
| Q2 FY2017 | Jun 30, 2017 | 27M | – |
See a number that looks wrong?